The Josep Carreras Leukaemia Research Institute (IJC) is a comprehensive cancer research center dedicated to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of leukaemia and other hematologic malignancies, with the final aim of finding a cure for these diseases. It was created in 2010, and since then has experienced an exponential growth.

The IJC is also part of the network of Excellence Research Centers of Catalonia (CERCA) and was accredited as a Severo Ochoa Center of Excellence by the Ministry of Science, Innovation, and Universities in 2024. Since 2018, the Institute has also been accredited by the Scientific Foundation of the Spanish Association Against Cancer (FCAECC) Additionally, IJC is one of the centers integrated into the Institut de Recerca Germans Trias i Pujol (IGTP) accreditation as Accredited Health Research Institute (IIS) by the Carlos III Health Institute (ISCIII).

The IJC's main headquarters is located within the Can Ruti Biomedical Campus, alongside other leading biomedical institutions, providing direct access to cutting-edge scientific and technological facilities, as well as complementary community services. The IJC has six locations integrated into reference hospitals: Hospital Germans Trias i Pujol, Hospital Clínic, Hospital Sant Pau, Hospital Josep Trueta, Hospital del Mar and Hospital San Joan de Déu. This facilitates close collaboration between basic and clinical researchers, fostering translational research that integrates basic science with clinical practice in clinical settings.

We are looking for a Postdoctoral Research for the Myelodysplastic syndromes (MDS) group, led by Dr. Francesc Sole.

RESEARCH DESCRIPTION

The MDS Group (IJC), seeks a highly motivated Postdoctoral Researcher to join translational projects focused on the cellular and molecular characterization of myeloid neoplasms and clonal hematopoiesis, aiming to uncover pathogenic mechanisms and therapeutic opportunities.

Working in a multidisciplinary environment of excellence, the selected candidate will contribute to ongoing projects such as:

• Decoding Multi-Lineage Evolutionary Trajectories in Patients under Adoptive Cell Therapies
• Immunological and Functional Characterization of Clonal Hematopoiesis in Thrombosis
• Reprogramming MYC in High-Risk Myeloid Neoplasms

MAIN RESPONSABILITIES

• Design, execution, and analysis of experiments using cellular and murine models of myeloid neoplasms.
• Integration, analysis, and interpretation of omics datasets in translational research.
• Supervision and mentorship of students and technical staff.
• Collaboration with clinical and basic investigators within IDIBAPS, IJC, and partner institutions.
• Contribution to scientific manuscripts, reports, and grant applications.

WHAT WE NEED

• PhD in Medicine, Biomedicine, Molecular Biology, Genetics, or related disciplines.
• Proven experience in translational or clinical research, preferably in hematology, oncology, or immunology.
• Hands-on expertise in molecular and cellular biology techniques (cell culture, PCR, NGS, Western blot, flow cytometry, lentiviral transduction, CRISPR, pharmacological and proteomic assays).
• Experience with animal experimentation (functions A–D certification).
• Background in bioinformatics and multi-omics data analysis (WES/WGS/scRNA-seq/Tapestri) is highly desirable.
• Strong publication record in peer-reviewed journals and participation in competitive research projects.
• High scientific rigor and strong analytical skills.
• Ability to work independently while maintaining a collaborative attitude in multidisciplinary settings.
• Proficiency in data analysis (genomic, transcriptomic, epigenomic).
• Ability to handle varying workloads and work effectively in a team.
• Excellent written and spoken scientific English.
• Strong collaborative and communication skills.
• Organizational skills, proactivity, and ability to manage multiple projects simultaneously.

WHAT WE OFFER

• Temporary position: 2 years, with the possibility of renewal for an additional year.
• Full time contract “Indefinido por actividades científico-técnicas”
• An exciting and innovative research project.
• Access to state-of-the-art facilities (NGS, flow cytometry, proteomics, bioinformatics, animal models).
• Working in the mixed basic and clinical research environment of the Josep Carreras Leukaemia Research Institute.
• Incorporation in a multinational and highly collaborative team.
• Flexible remuneration program (kindergarten and other measures).
• The stimulating environment of the Barcelona metropolitan area.

DEADLINE

Please submit your application by 26^t November 2025.

WHO WE ARE?

What makes us different?

The mission of the Josep Carreras Leukaemia Research Institute is to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of cancer, with a special emphasis on Leukaemia and other malignant blood diseases, with the aim of finding a cure for these diseases.
The IJC’s vision is to be a world-class reference and excellent research center that contributes to the improvement of results, and the cure of patients affected by leukaemia and other malignant haemopathies, through innovation, sustainability, social responsibility, talent, and professional experience.

HR Excellence

In 2019, IJC was honored with the “Human Resources Excellence in Research Award” by the European Commission, recognizing the alignment of our human resources policies with the European Charter for Researchers and Code of Conduct for the Recruitment of Researchers. The Human Resources Strategy for Researchers (HRS4R) guides research centers of excellence in implementing and upholding these standards within their policies, emphasizing training, professional development, and mobility opportunities.
The IJC’s commitment to these values and principles strengthens our internal policies and ensures that our members have the optimal conditions and environment for their professional development.
The Board of Trustees is composed of representatives of the Generalitat de Catalunya (regional government), University of Barcelona, Autonomous University of Barcelona, the City of Badalona and the Jose Carreras International Leukaemia Foundation
The Catalan government provides hard money on an annual basis. The Jose Carreras International Leukaemia Foundation provides start-up funds, project funds as well as financial support for investments.
The JCI has an international scientific advisory board served by prominent researchers from US and Europe.
The IJC has been awarded ERC and other EU grants.

The IJC is an equal-opportunity employer. We evaluate qualified applicants without regard to race, color, religion, sex, national origin, disability, or other legally protected characteristics.